Bank of America’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,502
Closed -$80.6K 8488
2024
Q2
$80.6K Sell
14,502
-9,022
-38% -$32K ﹤0.01% 6350
2024
Q1
$91.7K Buy
23,524
+2,728
+13% +$10.4K ﹤0.01% 6281
2023
Q4
$89.8K Buy
20,796
+18,296
+732% +$61.8K ﹤0.01% 6415
2023
Q3
$7.75K Buy
+2,500
New +$8.26K ﹤0.01% 6912
2023
Q1
Sell
-6
Closed -$16 8396
2022
Q4
$16 Buy
+6
New +$26 ﹤0.01% 8027
2022
Q1
Sell
-6
Closed 8900
2021
Q4
$0 Buy
+6
New +$29 ﹤0.01% 8767
2020
Q4
Sell
-112
Closed -$1K 7436
2020
Q3
$1K Buy
112
+41
+58% +$241 ﹤0.01% 6804
2020
Q2
$0 Buy
+71
New +$371 ﹤0.01% 7191
2019
Q3
Sell
-343
Closed -$5K 7575
2019
Q2
$5K Buy
+343
New +$4.83K ﹤0.01% 6852
2016
Q4
Sell
-381
Closed -$8K 7380
2016
Q3
$8K Sell
381
-543
-59% -$12.5K ﹤0.01% 6465
2016
Q2
$17K Buy
+924
New +$24.6K ﹤0.01% 6321
2016
Q1
Sell
-235
Closed -$9K 7390
2015
Q4
$9K Buy
235
+226
+2,511% +$9.81K ﹤0.01% 6727
2015
Q3
$0 Sell
9
-86
-91% -$4.84K ﹤0.01% 7455
2015
Q2
$7K Buy
95
+23
+32% +$1.59K ﹤0.01% 6717
2015
Q1
$5K Sell
72
-12
-14% -$944 ﹤0.01% 6514
2014
Q4
$7K Buy
84
+17
+25% +$1.38K ﹤0.01% 7180
2014
Q3
$5K Sell
67
-939
-93% -$80.2K ﹤0.01% 7559
2014
Q2
$90K Buy
1,006
+622
+162% +$55.2K ﹤0.01% 6219
2014
Q1
$45K Buy
384
+364
+1,820% +$35.4K ﹤0.01% 6487
2013
Q4
$1K Buy
20
+5
+33% +$204 ﹤0.01% 7753
2013
Q3
$1K Sell
15
-1,557
-99% -$97.7K ﹤0.01% 7764
2013
Q2
$115K Buy
+1,572
New +$90.7K ﹤0.01% 6080

Bank of America's ALIM Position: Q3 2024 in Review

Bank of America sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 14,502 shares — an estimated $80.6K sold.

Bank of America first reported a position in ALIM in Q2 2013 and held it in 22 quarters. The position peaked at $115K in Q2 2013. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

  • Bank of America reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
  • Bank of America sold 14,502 Alimera Sciences shares in Q3 2024, an estimated $80.6K.
  • Bank of America first reported a position in Alimera Sciences in Q2 2013 and held it in 22 quarters.
  • Bank of America's Alimera Sciences position peaked at $115K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on Bank of America's 13F filing for Q3 2024, filed 14 Nov 2024.